Pfiz­er sells off par­tial stake in Ha­le­on, po­ten­tial­ly rais­ing $2B+

Fol­low­ing in GSK’s foot­steps, Pfiz­er is sell­ing off about 630 mil­lion shares of its stake in con­sumer health spin­off Ha­le­on, re­duc­ing the Big Phar­ma’s stake from 32% to ap­prox­i­mate­ly 24%.

The of­fer­ing price, which will be an­nounced around March 19, will be set by a book build­ing process, Ha­le­on said Mon­day, adding that it will al­so re­pur­chase about $400 mil­lion of shares from Pfiz­er. Based on Ha­le­on’s last clos­ing price, Pfiz­er would raise about $2.58 bil­lion in sell­ing off 630 mil­lion shares.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER